Detalhe da pesquisa
1.
Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.
J Endovasc Ther
; 27(6): 936-945, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873131
2.
One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
J Endovasc Ther
; 24(3): 311-316, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351310
3.
Right-sided Cockett's syndrome.
Acta Chir Belg
; 116(2): 114-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27385298
4.
Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
J Endovasc Ther
; 22(1): 1-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25775672
5.
24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions.
Ann Vasc Surg
; 29(4): 738-50, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25733220
6.
4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.
J Endovasc Ther
; 20(6): 746-56, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24325689
7.
Durability and efficacy of the ELVeS® Radial® 2ring slim fiber for multiple ablations.
Phlebology
; 38(10): 641-648, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545129
8.
Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions.
JACC Cardiovasc Interv
; 16(23): 2900-2914, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092496
9.
ZILVERPASS Study: ZILVER PTX Stent vs. Bypass Surgery in Femoropopliteal Lesions, 3 year results and economic analysis.
J Cardiovasc Surg (Torino)
; 64(4): 413-421, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162238
10.
ZILVERPASS Study: ZILVER PTX Stent versus Prosthetic Above-the-Knee Bypass Surgery in Femoropopliteal Lesions, 5-year Results.
Cardiovasc Intervent Radiol
; 46(10): 1348-1358, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670198
11.
Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery.
Cardiovasc Intervent Radiol
; 45(12): 1855-1859, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36058996
12.
Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
J Vasc Surg
; 54(4): 1042-50, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21636239
13.
One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients.
J Cardiovasc Surg (Torino)
; 61(4): 445-450, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30994307
14.
Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.
J Cardiovasc Surg (Torino)
; 61(5): 617-625, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231029
15.
One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.
J Cardiovasc Surg (Torino)
; 61(4): 471-477, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241092
16.
BeGraft Peripheral PMCF Study: 12-month results.
J Cardiovasc Surg (Torino)
; 60(2): 230-236, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548472
17.
EVOLUTION Study: 12-month results.
J Cardiovasc Surg (Torino)
; 60(4): 490-495, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698370
18.
The impact of embolic protection device and stent design on the outcome of CAS.
Perspect Vasc Surg Endovasc Ther
; 20(3): 272-9, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18930936
19.
Drug-eluting stents in the management of peripheral arterial disease.
Vasc Health Risk Manag
; 4(3): 553-9, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18827906
20.
Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results.
J Cardiovasc Surg (Torino)
; 58(3): 416-421, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331010